
Megan Coylewright
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
Jul 1, 2026
New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI
48:55
48:59
49:04
R
48:47Roxana MehranMODERATOR
thinking about this change in what we've done going forward, or should there be change?

Megan CoylewrightGUEST
Let's all put our biases out in front of us right away before we say our comments.

Megan CoylewrightGUEST
And so, yeah, I spent my career making sure the patient voice is at the center.

Megan CoylewrightGUEST
But I've also spent a lot of time partnering with Tamara and others on a lot of the NCDs.
28 MINS LATER
B
77:08Basil RamlaouiGUEST
ACC, STS, very important to be able to say and in the absence of the stick of the NCD to have, you know, this is what we need to have the TAVR look like and this is where it's appropriate to use it and where the data's not there yet.